← Back to Search

Hydrogen Peroxide for Skin Cancer

Phase 2
Waitlist Available
Led By Jinka Sathya, MD
Research Sponsored by Jinka Sathya
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at study completion, an approximate of 1 year
Awards & highlights

Study Summary

This trial will test whether 30% hydrogen peroxide can help reduce the size of cancerous lesions, potentially avoiding surgery or radiation.

Eligible Conditions
  • Basal Cell Carcinoma
  • Squamous Cell Carcinoma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at study completion, an approximate of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and at study completion, an approximate of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in lesion size
Secondary outcome measures
Adverse Events
Change in the size of the radiation field
Local Control
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: 30% hydrogen peroxideExperimental Treatment1 Intervention
30% hydrogen peroxide liquid topical application. 2 drops (0.10 ml) of hydrogen peroxide solution per centimeter of lesion. Once every week for continuous 4 weeks. If there is complete clinical response, further hydrogen peroxide will not be done.
Group II: 3% hydrogen peroxidePlacebo Group1 Intervention
3% hydrogen peroxide liquid topical application. 2 drops (0.10 ml) of hydrogen peroxide solution per centimeter of lesion. Once every week for continuous 4 weeks. If there is complete clinical response, further hydrogen peroxide will not be done.

Find a Location

Who is running the clinical trial?

Jinka SathyaLead Sponsor
Lawson Health Research InstituteLead Sponsor
661 Previous Clinical Trials
413,871 Total Patients Enrolled
Jinka Sathya, MDPrincipal InvestigatorWestern University
1 Previous Clinical Trials
112 Total Patients Enrolled

Media Library

Hydrogen Peroxide 30 % Topical Solution Clinical Trial Eligibility Overview. Trial Name: NCT04929535 — Phase 2
Basal Cell Carcinoma Research Study Groups: 30% hydrogen peroxide, 3% hydrogen peroxide
Basal Cell Carcinoma Clinical Trial 2023: Hydrogen Peroxide 30 % Topical Solution Highlights & Side Effects. Trial Name: NCT04929535 — Phase 2
Hydrogen Peroxide 30 % Topical Solution 2023 Treatment Timeline for Medical Study. Trial Name: NCT04929535 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

For what treatments is Hydrogen Peroxide 30% Topical Solution typically applied?

"Hydrogen Peroxide 30 % Topical Solution is a viable therapy for treating ear infection bacterial, seborrheic keratosis, and communicable diseases."

Answered by AI

Is there any risk associated with utilizing Hydrogen Peroxide 30 % Topical Solution?

"Because of the absence of efficacy data, our team at Power has concluded that Hydrogen Peroxide 30 % Topical Solution is moderately safe and consequently awarded it a score of 2."

Answered by AI

Are there any precedents for this medical experiment?

"Kortuc, Inc. launched the initial clinical trial for Hydrogen Peroxide 30 % Topical Solution back in 2020, which included a cohort of 184 individuals. This study proved successful and saw the drug move to Phase 2 approval status. At present, 3 different trials are running across 5 cities throughout 3 countries internationally."

Answered by AI

What is the enrollment cap for this clinical investigation?

"Affirmative. Clinicaltrials.gov reports that this study, which was initially posted on September 1st 2022, is presently enrolling participants. It requires 51 individuals to be recruited from only one site."

Answered by AI

Is there still an opportunity to join this clinical trial?

"The records on clinicaltrials.gov demonstrate that this medical trial is actively searching for participants. It was initially published on September 1st 2022, with the most recent post being made on August 29th 2022."

Answered by AI

What previous investigations have been conducted involving Hydrogen Peroxide 30 % Topical Solution?

"Currently, 3 medical trials involving Hydrogen Peroxide 30 % Topical Solution are actively enrolling participants. As the majority of studies for this treatment take place in Lucknow, Uttar Pradesh, there exists 9 clinical sites offering it across the nation."

Answered by AI
~19 spots leftby May 2025